Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Topics : Population groups
  • Active substance : entacapone
Filter
Topic
  • Diseases and conditions (2)
  • Plus ...
    • Nervous system diseases (2)
    • Plus ...
      • Neurodegenerative diseases (2)
      • Central nervous system diseases (2)
  • Population groups (2)
  • Plus ...
    • Geriatrics (2)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Drug therapy (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Medicine (1)
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Chronic disease guide (1)
Date
  • Last five years (2)
Langue
  • Français (2)
Substance active
  • entacapone (2)
  • iode (1)
  • rasagiline (1)
  • ropinirole (1)
  • rotigotine (1)
  • tolcapone (1)
More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 1 result

  • Irreversible secondary or degenerative parkinsonian syndromes

    Chronic disease guide - Posted on 15/9/2021 - Mis à jour le 15/9/2021
    Add to my selection

Drugs, devices and medical acts - 1 result

  • LECIGIMON (lévodopa/ carbidopa/ entacapone)

    Medicine - Posted on 9/1/2023
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
bM5PK8E4p7rg9xk4